×
About 3,485 results

ALLMedicine™ Optic Neuritis Center

Research & Reviews  1,088 results

Imaging of Complications of Chemoradiation.
https://doi.org/10.1016/j.nic.2021.08.012
Neuroimaging Clinics of North America; Raghavan P, Witek ME et. al.

Nov 24th, 2021 - Chemoradiation for head and neck cancer is associated with a variety of early and late complications. Toxicities may affect the aero-digestive tract (mucositis, salivary gland injury), regional osseous and cartilaginous structures (osteoradionecro...

A case of bilateral limbic and recurrent unilateral cortical encephalitis with anti-mye...
https://doi.org/10.1016/j.braindev.2021.10.011
Brain & Development; Horita T, Inoue T et. al.

Nov 23rd, 2021 - Anti-myelin oligodendrocyte glycoprotein (MOG) antibody can be detected not only in acute disseminated encephalomyelitis or optic neuritis but also in limbic or cortical encephalitis. However, no previous reports have demonstrated a relapsing case...

Chiasmatic lesions on conventional magnetic resonance imaging during the first event of...
https://doi.org/10.1111/ene.15178
European Journal of Neurology; Carnero Contentti E, López PA et. al.

Nov 21st, 2021 - Optic neuritis (ON) is often the initial symptom of neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein-associated disease (MOGAD). We aimed to compare the frequency and pattern of chiasmatic lesions in MOGAD-rel...

Erythropoietin and optic neuritis in the TONE study.
https://doi.org/10.1016/S1474-4422(21)00378-1
The Lancet. Neurology; Costello F

Nov 21st, 2021 - Erythropoietin and optic neuritis in the TONE study.|2021|Costello F,|

see more →

Guidelines  1 results

EULAR recommendations for the management of systemic lupus erythematosus with neuropsyc...
https://doi.org/10.1136/ard.2010.130476
Annals of the Rheumatic Diseases; Bertsias GK, Ioannidis JP et. al.

Aug 21st, 2010 - To develop recommendations for the diagnosis, prevention and treatment of neuropsychiatric systemic lupus erythematosus (NPSLE) manifestations. The authors compiled questions on prevalence and risk factors, diagnosis and monitoring, therapy and pr...

see more →

Drugs  145 results see all →

Clinicaltrials.gov  32 results

Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
https://clinicaltrials.gov/ct2/show/NCT02521311

Nov 5th, 2021 - Optic neuritis is an inflammatory, demyelinating disease of the optic nerve. It is most often characterized by visual loss or blurred vision along with dyschromatopsiaaccompanied by pain (especially with eye movement) and no demonstrable evidence ...

Natural History of Optic Neuritis
https://clinicaltrials.gov/ct2/show/NCT01851434

Sep 14th, 2021 - Objective The goals of this pilot study are: To assess the degree to which subacute changes in clinical, electrophysiological, and imaging measures can robustly predict retinal neuronal loss 12 months after acute optic neuritis. To construct a com...

MOdification of VIsual Outcomes After Optic Neuritis in CIS or MS by Gilenya (MOVING Study)
https://clinicaltrials.gov/ct2/show/NCT01647880

Jul 29th, 2021 - In the MOVING study should be examined, whether early therapeutic intervention with fingolimod (Gilenya ®) after optic neuritis(ON) has a favorable visual outcome as a comparative therapie with Interferon beta-1b (Extavia®), as measured by multifo...

RESting-state Functional MRI in Patients With Optic Neuritis for ANticipation of reCovEry
https://clinicaltrials.gov/ct2/show/NCT04448938

Jul 16th, 2021 - When patients arrive in the waiting room of the MRI department, patients will be given the briefing note explaining the purpose of the study and how it is going. During the consultation, the radiologist will check the inclusion and non-inclusion c...

The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders
https://clinicaltrials.gov/ct2/show/NCT01623076

May 19th, 2021 - This study seeks to determine the biologic causes of inflammation in patients with Neuromyelitis Optica (NMO), Transverse Myelitis (TM), optic neuritis (ON), related conditions and healthy controls. While patients will be treated according to deci...

see more →

News  122 results

Erythropoietin Falls Short of Neuroprotection in Optic Neuritis
https://www.medscape.com/viewarticle/946851

Mar 4th, 2021 - Erythropoietin (EPO), shown in early studies to potentially provide neuroprotection for patients with optic neuritis, failed to provide any significant neuroprotection in comparison with placebo in a phase 3 randomized controlled trial. "EPO conve...

Newer DMTs More Effective vs Injectables in Pediatric MS
https://www.medscape.com/viewarticle/939952

Oct 28th, 2020 - Among patients with pediatric-onset relapsing-remitting multiple sclerosis (MS), newer disease-modifying therapies (DMTs) reduce clinical and radiological disease activity more effectively than older injectable therapies. Nevertheless, all DMTs re...

New Developments, Challenges in Treating NMOSD
https://www.staging.medscape.com/viewarticle/939569

Oct 22nd, 2020 - New developments in treatment of neuromyelitis optica spectrum disorder (NMOSD) have opened up options for disease treatment in pediatric patients, but have led to some uncertainty and confusion as well. At the2020 CNS-ICNA Conjoint Meeting, held ...

New Developments, Challenges in Treating NMOSD
https://www.medscape.com/viewarticle/939569

Oct 22nd, 2020 - New developments in treatment of neuromyelitis optica spectrum disorder (NMOSD) have opened up options for disease treatment in pediatric patients, but have led to some uncertainty and confusion as well. At the2020 CNS-ICNA Conjoint Meeting, held ...

NMOSD challenges in children
https://www.mdedge.com/neurology/article/230384/rare-diseases/nmosd-challenges-children
Jim Kling

Oct 21st, 2020 - New developments in treatment of neuromyelitis optica spectrum disorder (NMOSD) have opened up options for disease treatment in pediatric patients, but have led to some uncertainty and confusion as well. At the2020 CNS-ICNA Conjoint Meeting, held.

see more →

Patient Education  6 results see all →